3 patients die in cancer drug trial
Merus is studying a new antibody therapy for non-small cell lung cancer which has seen some success, however three patients have died
European Society For Medical Oncology Asia Congress European Society Medical Oncology Sasia Congress Lung Cancer Cla 129
Source: beckershospitalreview.com